• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型人类树突状细胞的非病毒转染:通过电穿孔实现高效基因转移至造血祖细胞来源而非单核细胞来源的树突状细胞。

Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.

作者信息

Van Tendeloo V F, Snoeck H W, Lardon F, Vanham G L, Nijs G, Lenjou M, Hendriks L, Van Broeckhoven C, Moulijn A, Rodrigus I, Verdonk P, Van Bockstaele D R, Berneman Z N

机构信息

Laboratory of Experimental Hematology, University of Antwerp (UIA/UZA), Belgium.

出版信息

Gene Ther. 1998 May;5(5):700-7. doi: 10.1038/sj.gt.3300626.

DOI:10.1038/sj.gt.3300626
PMID:9797876
Abstract

Human dendritic cells (DC) are highly professional antigen presenting cells for the priming of naive cytotoxic T cells. Gene transfer in DC would be a useful strategy to load DC with relevant de novo synthesized antigens for immunotherapeutical purposes. As a first step towards a DC-based gene therapy, we examined the efficiency of nonviral transfection in different types of cultured human dendritic cells with a humanized red-shifted green fluorescent protein reporter gene. Plasmid DNA transfection by electroporation or lipofection was used to transfect CD34+ progenitor cell-derived DC (PC-DC) and Langerhans' cells (PC-LC), as well as monocyte-derived DC (Mo-DC). While lipofection was unsuccessful in all types of DC, we obtained high-efficiency gene transfer by electroporation in PC-LC (16%) and PC-DC (12%). In contrast, electroporation was strikingly less efficient in Mo-DC (< or = 2%). The potent allostimulatory capacity of DC was still retained in electroporated PC-DC and PC-LC. In conclusion, electroporation of antigen expressing plasmid DNA is an efficient tool for nonviral gene transfer in PC-DC and PC-LC, but not in Mo-DC and could be useful for the development of DC-based tumor immunotherapy.

摘要

人树突状细胞(DC)是用于启动幼稚细胞毒性T细胞的高度专业的抗原呈递细胞。将基因导入DC可能是一种有用的策略,可用于为免疫治疗目的加载新合成的相关抗原。作为基于DC的基因治疗的第一步,我们用一种人源化的红移绿色荧光蛋白报告基因检测了不同类型培养的人树突状细胞中非病毒转染的效率。通过电穿孔或脂质体转染质粒DNA来转染CD34 +祖细胞衍生的DC(PC-DC)和朗格汉斯细胞(PC-LC)以及单核细胞衍生的DC(Mo-DC)。虽然脂质体转染在所有类型的DC中均未成功,但我们通过电穿孔在PC-LC(16%)和PC-DC(12%)中获得了高效的基因转移。相比之下,电穿孔在Mo-DC中的效率极低(≤2%)。电穿孔后的PC-DC和PC-LC仍保留了DC强大的共刺激能力。总之,表达抗原的质粒DNA的电穿孔是PC-DC和PC-LC中非病毒基因转移的有效工具,但不适用于Mo-DC,并且可能对基于DC的肿瘤免疫治疗的发展有用。

相似文献

1
Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.不同类型人类树突状细胞的非病毒转染:通过电穿孔实现高效基因转移至造血祖细胞来源而非单核细胞来源的树突状细胞。
Gene Ther. 1998 May;5(5):700-7. doi: 10.1038/sj.gt.3300626.
2
Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.人脐带血树突状细胞的非病毒转染是可行的,但具有转基因表达的树突状细胞产量限制了该方法在癌症免疫治疗中的应用。
Acta Biochim Pol. 2006;53(1):203-12. Epub 2006 Jan 9.
3
CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.通过电穿孔用肿瘤肽cDNA转染的CD83 +人树突状细胞诱导特异性T细胞反应:一种基因免疫治疗的潜在工具。
Cancer Gene Ther. 2000 Apr;7(4):605-14. doi: 10.1038/sj.cgt.7700187.
4
High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer.非病毒基因转移后单核细胞衍生的人树突状细胞具有高转染效率、基因表达及活力。
J Leukoc Biol. 2007 Oct;82(4):849-60. doi: 10.1189/jlb.0906561. Epub 2007 Jul 12.
5
Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.用编码流感病毒基质蛋白M1的RNA或DNA转染的人树突状细胞在刺激细胞毒性T淋巴细胞的能力上存在差异。
Gene Ther. 2000 Dec;7(23):2028-35. doi: 10.1038/sj.gt.3301326.
6
Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.从CD34+造血祖细胞产生的树突状细胞亚群可以用mRNA转染并诱导抗原特异性细胞毒性T细胞反应。
J Immunol Methods. 2004 Feb 15;285(2):171-80. doi: 10.1016/j.jim.2003.11.012.
7
High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.人脐带血CD34+造血前体细胞的高效电穿孔
Stem Cells. 2001;19(6):492-9. doi: 10.1634/stemcells.19-6-492.
8
An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.一种通过对CD14+单核细胞进行直接电穿孔来生成免疫活性树突状细胞的改进方案。
J Immunol Methods. 2007 Apr 10;321(1-2):94-106. doi: 10.1016/j.jim.2007.01.004. Epub 2007 Feb 5.
9
Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.通过直接在培养基中进行单核细胞淘析、随后在袋中培养以及使用肽或RNA转染进行最终抗原加载,有效进行临床规模的树突状细胞疫苗生产。
J Immunother. 2007 Sep;30(6):663-74. doi: 10.1097/CJI.0b013e3180ca7cd6.
10
Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation.在未经预刺激的情况下,通过电穿孔法将基因导入纯化的人外周血造血干细胞。
J Lab Clin Med. 2003 Feb;141(2):138-49. doi: 10.1067/mlc.2003.14.

引用本文的文献

1
Lipid carriers for mRNA delivery.用于mRNA递送的脂质载体。
Acta Pharm Sin B. 2023 Oct;13(10):4105-4126. doi: 10.1016/j.apsb.2022.11.026. Epub 2022 Nov 30.
2
Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.mRNA 疫苗分子设计与递送技术的最新进展:用于传染病防控
Front Immunol. 2022 Jul 15;13:896958. doi: 10.3389/fimmu.2022.896958. eCollection 2022.
3
Lipofection mediated transfection fails for sea urchin coelomocytes.脂质体介导的转染对海胆腔细胞无效。
PLoS One. 2022 May 6;17(5):e0267911. doi: 10.1371/journal.pone.0267911. eCollection 2022.
4
Clinical and immunological effects of mRNA vaccines in malignant diseases.mRNA 疫苗在恶性疾病中的临床和免疫效果。
Mol Cancer. 2021 Mar 15;20(1):52. doi: 10.1186/s12943-021-01339-1.
5
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines.纳米颗粒作为基于mRNA疫苗的佐剂和纳米递送系统
Pharmaceutics. 2020 Dec 30;13(1):45. doi: 10.3390/pharmaceutics13010045.
6
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.细胞膜破坏介导的细胞内递送:机制、策略和概念。
Chem Rev. 2018 Aug 22;118(16):7409-7531. doi: 10.1021/acs.chemrev.7b00678. Epub 2018 Jul 27.
7
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.基于非病毒载体的递药系统的 mRNA 治疗药物递送中的纳米技术。
Gene Ther. 2017 Mar;24(3):133-143. doi: 10.1038/gt.2017.5. Epub 2017 Jan 17.
8
mRNA-based therapeutics--developing a new class of drugs.mRNA 疗法——开发一类新药。
Nat Rev Drug Discov. 2014 Oct;13(10):759-80. doi: 10.1038/nrd4278. Epub 2014 Sep 19.
9
CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?CD8(+) T 细胞的初始激活和增强:更多的抗原呈递树突状细胞,还是每个树突状细胞上更多的抗原?
Cancer Immunol Immunother. 2013 Dec;62(12):1769-80. doi: 10.1007/s00262-013-1481-z. Epub 2013 Oct 10.
10
Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation.高效高通量质粒和 siRNA 转染人单核细胞来源树突状细胞而不诱导细胞成熟的验证。
J Immunol Methods. 2010 Dec 15;363(1):21-8. doi: 10.1016/j.jim.2010.09.028. Epub 2010 Sep 24.